Adabiyotlar
1. Bell, J. L. et al. Insulin-like growth factor 2 mRNA-binding proteins
(IGF2BPs): post-transcriptional drivers of cancer progression?
Cell. Mol.
Life Sci. 70, 2657–2675 (2013).
2. Nielsen, J. et al. A family of insulin-like growth factor
II mRNA-binding
proteins represses translation in late development.
Mol. Cell. Biol. 19, 1262–
1270 (1999).
3. Ennajdaoui, H. et al. IGF2BP3 modulates the
interaction of invasion-
associated transcripts with RISC.
Cell Rep. 15, 1876–1883 (2016).
4. Degrauwe, N., Suvà, M. L., Janiszewska, M., Riggi, N. & Stamenkovic, I.
IMPs: an RNA-binding protein family that provides a link between stem cell
maintenance in normal development and cancer.
Genes Dev. 30, 2459–2474
(2016a).
5. Farina, K. L., Hüttelmaier, S., Musunuru, K., Darnell, R. & Singer, R. H.
Two ZBP1 KH domains facilitate β-actin mRNA localization, granule
formation, and cytoskeletal attachment.
J. Cell. Biol. 160, 77–87 (2003)..
6. Hüttelmaier, S. et al. Spatial regulation of β-actin translation by Src-
dependent phosphorylation of ZBP1.
Nature 438, 512–515 (2005).
7. Jønson, L. et al. Molecular composition of IMP1 ribonucleoprotein
granules.
Mol. Cell. Proteom. 6, 798–811 (2007).
8. Weidensdorfer, D. et al. Control of c-myc mRNA stability by IGF2BP1-
associated cytoplasmic RNPs.
RNA 15, 104–115 (2009)..